Výsledky vyhledávání

Akademický článek

Biotechnological aspects of the working-out and manufacturing of living bone equivalent.

Autor: Zubov, D. O.^1,2,3 zoubov77@yahoo.com, Poliachenko, Y. V.¹ info@ito.gov.ua, Kostrub, O. O.¹ akostrub@ukr.net, Blonskyi, R. I.¹ drblonskiy@ukr.net, Magomedov, O. M.¹ alexandr@magomedov.kiev.ua, Dolgopolov, O. V.¹ ortotravma.kiev@gmail.com, Zasadnyuk, I. A.¹ zasadnyuk@ukr.net

Publikováno v: Orthopaedics, Traumatology & Prosthetics / Ortopediia, Traumatologiia i Protezirovaniie. 2023, Issue 4, p87-92. 6p.

Zobrazit plný text záznamu

Akademický článek

Discovery and Preclinical Characterization of Fulacimstat (BAY 1142524), a Potent and Selective Chymase Inhibitor As a New Profibrinolytic Approach for Safe Thrombus Resolution.

Autor: Fürstner C; Bayer AG, Pharmaceuticals, Research and Development, Aprather Weg 18a, 42113 Wuppertal, Germany., Ackerstaff J; Bayer AG, Pharmaceuticals, Research and Development, Aprather Weg 18a, 42113 Wuppertal, Germany., Meier H; Bayer AG, Pharmaceuticals, Research and Development, Aprather Weg 18a, 42113 Wuppertal, Germany., Straub A; Bayer AG, Pharmaceuticals, Research and Development, Aprather Weg 18a, 42113 Wuppertal, Germany., Mittendorf J; Bayer AG, Pharmaceuticals, Research and Development, Aprather Weg 18a, 42113 Wuppertal, Germany., Schamberger J; Bayer AG, Pharmaceuticals, Research and Development, Aprather Weg 18a, 42113 Wuppertal, Germany., Schäfer M; Bayer AG, Pharmaceuticals, Research and Development, Müllerstrasse 178, 13353 Berlin, Germany., Börngen K; Bayer AG, Pharmaceuticals, Research and Development, Aprather Weg 18a, 42113 Wuppertal, Germany., Jörißen H; Bayer AG, Pharmaceuticals, Research and Development, Aprather Weg 18a, 42113 Wuppertal, Germany., Zubov D; Bayer AG, Pharmaceuticals, Research and Development, Aprather Weg 18a, 42113 Wuppertal, Germany., Zimmermann K; Bayer AG, Pharmaceuticals, Research and Development, Aprather Weg 18a, 42113 Wuppertal, Germany., Tersteegen A; Bayer AG, Pharmaceuticals, Research and Development, Aprather Weg 18a, 42113 Wuppertal, Germany., Geiss V; Bayer AG, Pharmaceuticals, Research and Development, Aprather Weg 18a, 42113 Wuppertal, Germany., Hartmann E; Bayer AG, Pharmaceuticals, Research and Development, Aprather Weg 18a, 42113 Wuppertal, Germany., Albrecht-Küpper B; Bayer AG, Pharmaceuticals, Research and Development, Aprather Weg 18a, 42113 Wuppertal, Germany., D'Orléans-Juste P; Department of Pharmacology and Physiology, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, 3001, 12e Avenue Nord, Sherbrooke, QC J1H 5N4, Canada., Lapointe C; Department of Pharmacology and Physiology, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, 3001, 12e Avenue Nord, Sherbrooke, QC J1H 5N4, Canada., Vincent L; Department of Pharmacology and Physiology, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, 3001, 12e Avenue Nord, Sherbrooke, QC J1H 5N4, Canada., Heitmeier S; Bayer AG, Pharmaceuticals, Research and Development, Aprather Weg 18a, 42113 Wuppertal, Germany., Tinel H; Bayer AG, Pharmaceuticals, Research and Development, Aprather Weg 18a, 42113 Wuppertal, Germany.

Publikováno v: Journal of medicinal chemistry [J Med Chem] 2024 Nov 14. Date of Electronic Publication: 2024 Nov 14.

Zobrazit plný text záznamu

Report

Chiral tunneling through generic one-dimensional potential barriers in bilayer graphene

Autor: Kleptsyn, V., Okunev, A., Schurov, I., Zubov, D., Katsnelson, M. I.

Publikováno v: Phys. Rev. B 92, 165407 (2015)

We study tunneling of charge carriers in single- and bilayer graphene. We propose an explanation for non-zero "magic angles" with 100% transmission for the case of symmetric potential barrier, as well as for their almost-survival for slightly asymmet

Externí odkaz: http://arxiv.org/abs/1507.07638

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 Inhibitor.

Autor: Meibom D; Bayer AG, 42113 Wuppertal, Germany., Wasnaire P; Bayer AG, 42113 Wuppertal, Germany., Beyer K; Bayer AG, 42113 Wuppertal, Germany., Broehl A; Bayer AG, 42113 Wuppertal, Germany., Cancho-Grande Y; Bayer AG, 42113 Wuppertal, Germany., Elowe N; Broad Institute, 02142 Cambridge, United States., Henninger K; Bayer AG, 42113 Wuppertal, Germany., Johannes S; Bayer AG, 42113 Wuppertal, Germany., Jungmann N; Bayer AG, 42113 Wuppertal, Germany., Krainz T; Broad Institute, 02142 Cambridge, United States., Lindner N; Bayer AG, 42113 Wuppertal, Germany., Maassen S; Bayer AG, 42113 Wuppertal, Germany., MacDonald B; Broad Institute, 02142 Cambridge, United States., Menshykau D; Bayer AG, 42113 Wuppertal, Germany., Mittendorf J; Bayer AG, 42113 Wuppertal, Germany., Sanchez G; Villapharma Research, 30320 Murcia, Spain., Schaefer M; Bayer AG, 13353 Berlin, Germany., Stefan E; Broad Institute, 02142 Cambridge, United States., Torge A; Bayer AG, 42113 Wuppertal, Germany., Xing Y; Broad Institute, 02142 Cambridge, United States., Zubov D; Bayer AG, 42113 Wuppertal, Germany.

Publikováno v: Journal of medicinal chemistry [J Med Chem] 2024 Feb 22; Vol. 67 (4), pp. 2907-2940. Date of Electronic Publication: 2024 Feb 13.

Zobrazit plný text záznamu

Features of the Foreign Exchange Market in the Russian Federation

Autor: Zubov, D.

Работа посвящена анализу отличительных черт функционирования валютного рынка в Российской Федерации. В ходе исследования были изучены

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______917::1997dd351f2ddba3c2f90dd5da8e3725
https://hdl.handle.net/10995/108841

Zobrazit plný text záznamu

Akademický článek

Discovery of VIP236, an αvβ3-Targeted Small-Molecule-Drug Conjugate with Neutrophil Elastase-Mediated Activation of 7-Ethyl Camptothecin Payload for Treatment of Solid Tumors.

Autor: Lerchen HG; Vincerx Pharma GmbH, 40789 Monheim, Germany., Stelte-Ludwig B; Vincerx Pharma GmbH, 40789 Monheim, Germany., Heroult M; Bayer AG, 65926 Frankfurt, Germany., Zubov D; Bayer AG, 42096 Wuppertal, Germany., Gericke KM; Bayer AG, 42096 Wuppertal, Germany., Wong H; Vincerx Pharma, Inc., Palo Alto, CA 94306, USA., Frigault MM; Vincerx Pharma, Inc., Palo Alto, CA 94306, USA., Johnson AJ; Vincerx Pharma, Inc., Palo Alto, CA 94306, USA., Izumi R; Vincerx Pharma, Inc., Palo Alto, CA 94306, USA., Hamdy A; Vincerx Pharma, Inc., Palo Alto, CA 94306, USA.

Publikováno v: Cancers [Cancers (Basel)] 2023 Sep 01; Vol. 15 (17). Date of Electronic Publication: 2023 Sep 01.

Zobrazit plný text záznamu

Plný text ve formátu HTML

PROTOTYPING SMART HOME FOR IMMOBILIZED PEOPLE: EEG/MQTT-BASED BRAIN-TO-THING COMMUNICATION

Autor: Qureshi, M. S., Kose, U., Kupin, A., Zubov, D. A.

Publikováno v: Radio Electronics, Computer Science, Control. :90

Context. Immobilized people face additional barriers in almost all areas of life, including simple operations like turning the light on/off and controlling the air conditioner. The object of the study was to develop the brain-to-thin communication of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e09f9a53f2a9e44b1ce1f9643e46b14
https://doi.org/10.15588/1607-3274-2022-2-9

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání